GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (TSE:4507) » Definitions » Total Equity

Shionogi (TSE:4507) Total Equity : 円1,252,561 Mil (As of Mar. 2024)


View and export this data going back to 1949. Start your Free Trial

What is Shionogi Total Equity?

Shionogi's total equity for the quarter that ended in Mar. 2024 was 円1,252,561 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Shionogi Total Equity Historical Data

The historical data trend for Shionogi's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Total Equity Chart

Shionogi Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 765,203.00 864,550.00 993,285.00 1,121,878.00 1,252,561.00

Shionogi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,121,878.00 1,192,178.00 1,231,432.00 1,214,342.00 1,252,561.00

Shionogi Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Shionogi's Total Equity for the fiscal year that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1416918-164357
=1,252,561

Shionogi's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=1416918-164357
=1,252,561

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shionogi Total Equity Related Terms

Thank you for viewing the detailed overview of Shionogi's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shionogi (TSE:4507) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (TSE:4507) » Definitions » Total Equity
Comparable Companies
TSE:4523 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 TSE:4534 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
SGIOY:USA SGIOF:USA SH0:Germany
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
http://www.shionogi.co.jp
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (TSE:4507) Headlines

No Headlines